Talking Euretina

As applications open for the Euretina Retinal Medicine Clinical Research Award, we hear about the award from Euretina EVP, Dara Conlon. We also gain interesting insights from previous winners Camiel Boon (Netherlands) and João Pedro Marques (Portugal) to see how the award has furthered their research.

In this podcast Euretina President, Mr Alistair Laidlaw and Euretina EVP Dara Conlon explore the highlights of this year's congress which is on track to be the biggest and most exciting meeting yet!

In this episode, journalist Ramadan Younis and his executive producer Simon Cox tell us about their far-reaching BBC documentary. "Blind Faith" exposes the international practice of defrauding patients of Retinitis Pigmentosa with false hopes of treatment or cure with little or no evidence of efficacy. They are joined by Prof Robert McLaren of the University of Oxford, who consulted on the documentary and evaluated the scientific claims being made by bad actors in the programme. You can watch the documentary here: https://www.bbc.co.uk/programmes/p0f95ky3

In this episode, we’re going to dig into the subject of this year’s Ophtalmologica lecture which will be delivered on the Saturday afternoon at this year’s congress in Amsterdam. Professor Maximilan Pfau is a clinician with a specialism in AMD and Inherited Retinal diseases in the Department of Ophthalmology at the University Eye Hospital, Basel, Switzerland. He's joined by Editor in Chief of the Ophthalmologica Journal; Professor Martin Zinkernagel

In this episode, we head to Asia to hear from colleagues in Japan, Singapore and South Korea about their experiences treating PCV and Pachychoroid in different populations. The podcast is chaired by Prof Taiji Sakamoto (Japan) and Prof SeungYoung Yu (South Korea) who are joined by Prof Gemmy Cheung and Prof Adrian Koh (Singapore)

In this podcast, we hear from Euretina Keynote Bertil Damato (UK/Sweden) about his upcoming talk on OncoVR at the 2023 Euretina Congress. He is joined by colleague Carl Groenewald (UK) and Heinrich Heimann (Chair - UK)

In this podcast, we'll be hearing about an exciting new event taking
place in Amsterdam at the Euretina Congress in October; the inaugural
Euretina Innovation Summit (EIS). Kourous Rezaei (USA) and Anat
Loewenstein (Israel) - two members of the organising committee - will
discuss the programme and motivation behind the event with chair Frank
G Holz (Germany)

In this podcast, we’ll explore two areas in the subspecialty of myopia: Aude Couturier will share her expertise in macular holes and Dr Yves Lachkar will discuss glaucoma in highly myopic patients. Chaired by David Gaucher and Jost Jonas

In this episode, Editor in Chief at Ophthalmologica, Professor Martin Zinkernagel discusses two featured papers from Euretina’s official journal. The first paper discussed covers choroiditis and the second covers effective treatment regimen in macular degeneration. Faculty are Dr Jeannette Ossewaarde-van Norel and Evianne de Groot (University Medical Center Utrecht) and Mathis Thibaud, Red Cross University Hospital, Lyon

In this episode, we explore how to diagnose and treat intraocular lymphoma with a panel of leading retinal surgeons and oncologists. Dr Hibba Quhill chairs the discussion with Professors Carlos Pavesio and Mandeep Sagoo from Moorfields Eye Hospital, London.

In this episode, we will hear all of the tips and tricks to success when looking to submit your research to Ophthalmologica.

Faculty: Martin Zinkernagel (Ophthalmologica editors) and Marco Casola (Karger).

Chaired by Jonathan McCrea

In this episode, Edoardo Midena (Italy) chairs a discussion with four leading experts in Diabetic Retinopathy from across the world: Jakob Grauslund (Denmark), Carol Cheung (Hong Kong), Enrico Borrelli (Italy) and Daniel Ting (Singapore)

In this episode, Siegfried Priglinger (Germany) and Roxane Hillier (UK) take a look at treatment for macula-off RRD. They're joined by David Yorston (Scotland) and Julian Klaas (Germany) and will ask - how do we best define "macula-off" and when should we start treatment?

Treating rare diseases can sometimes be challenging due a the lack of literature. In this episode, Carlos Pavesio (UK) asks leading experts Sara Touhami (France) and Moncef Khairallah (Tunisia) about their approaches to the diagnosis and treatment of Acute Retinal Necrosis (ARN).

In this podcast, David Steel tells Alistair Laidlaw what he's learned from zeroing in on individual patient data and how factors like posture and hole size affect his decision-making in the treatment of macular holes

In this episode, Euretina President Alistair Laidlaw chairs a discussion with Nicole Eter (München University Medical Centre) and Brendan Strong, Head of Education at Agenda about the new EBO examination.

In this in-depth podcast, Euretina President-Elect Ramin Tadayoni (France) chairs a discussion with Kyoko Ohno Matsui (Japan) and David Gaucher (France) exploring everything you need to know when dealing with the “bad guy” in myopia - Staphyloma.

Panel: Prof Ramin Tadayoni, University Of Paris Cite, Lariboisière, Saint Louis And Adolphe De Rothschild Foundation Hospitals, France

Kyoko Ohno Matsui Tokyo Medical And Dental University, Japan

David Gaucher Dept Of Ophthalmology, University Of Strasbourg, France

In this episode, Hibba Quhill (UK) explores each of the components that make up the MOLES system used for management of melanocytic choroidal tumours with the system's originator, Bertil Damato (UK/Sweden).

 In this episode we will look at the Derby and Oaks trials; two trials looking at geographic atrophy associated with AMD. The session is chaired by Professor Frank Holz (Germany), featuring Professors Adnan Tufail (UK) and Sandrine Zweifel (Switzerland).

Worried you missed out on some great content at EURETINA? Don't worry! In this episode, we look back on the best Euretina sessions from the Congress. Joining us to give us their highlights from Hamburg are: Alistair Laidlaw, Euretina President, Ramin Tadayoni (France) and Kourous Rezaei (USA)

In this episode, we catch up with Professors Camiel Boon, Tunde Peto and Dr Patricia Udaondo (New University and Polytechnic Hospital La Fe, Valencia) fresh from an incredible event in Hamburg to hear all about their highlights of the congress. They'll share their standout sessions that you need to catch up on via the Euretina portal at www.euretina.org

Euretina 2022 Hamburg highlights:

Tunde Peto:

Euretina Lecture - Sobha Sivaprasad 

Euretina Session 10: Inherited Retinal Diseases

Subspecialty Sessions - Euretina IRD ERN-EYE session

Camiel Boon: 

Subspecialty Sessions - Euretina IRD ERN-EYE session

Euretina Session 14 - CSC

World Retina Day - Singapore Society of Ophthalmology Session:

Patricia Eduaondo: 

Euretina session 4 - Vitreoretinal Surgery I: Management of silicone oil complications

Euretina session 8 - Late Breakings 

Euretina session 15 - Vitreoretinal Surgery II

World Retina Day - Spanish Society of Retina and Vitreous (SERV)  Vitreoretinal surgery in complex trauma cases

In this episode, we will again hear from two of our keynote speakers at the Euretina congress in Hamburg this September. Prof Hiroko Terasaki (Japan) who will give the Kreissig Lecture on Sept 3rd at Euretina (interviewed by Professor Ramin Tadayoni, Euretina President Elect) and Dr Enrico Borrelli (Italy) who will give the Ophthalmologica lecture (interviewed by Prof Frank Holz, Bonn, former Euretina President).

In this episode Euretina President Mr Alistair Laidlaw previews two of our keynote speakers from this year's Euretina Congress in Hamburg. He is joined by Professor Sobha Sivaprasad (UK) and Professor Catherine Creuzot-Garcher (France)

Talking Euretina is taking a short break but will be back in August

In this episode, we explore non-invasive imaging of retinal diseases in a discussion chaired by Dr Stela Vujosevic ( Italy). Our faculty are Dr Bianca Gerendas, Medical University of Vienna and Dr Amani Fawzi, Northwestern University of Chicago.

In this episode, we return to the topic of ocular oncology to explore choroidal naevi in daily practice, through Imaging, follow-ups and the MOLES system. This expert discussion is chaired by Heinrich Heimann who is joined by Prof Bertil Damato, Dr Rumana Hussain, Dr Iwona Rospond-Kubiak and Dr Jose Caminal.

This Journal Club is all about subretinal hemorrhaging as we take a look at 2 relevant papers and hear the latest developments of the Euretina-sponsored TIGER Study. It is chaired by Professors Grazia Pertile (Sacro Cuore Hospital Negrar, Verona) and Siegfried Priglinger (LMU Munich).  They're joined by Professor Timothy Jackson (King’s College, London), Dr Emilia Maggio (Sacro Cuore Hospital Negrar, Verona) and Dr Saskia van Romunde (The Rotterdam Eye Hospital)

In this episode, Professor Sandrine Zweifel (Switzerland) and Professor Adnan Tufail (UK) chair a discussion on how imaging has affected our understanding of AMD. They discuss the impact of new biomarkers and also explore the effect of big data on this field now and into the future. Contributing faculty are Professor Christine Curcio (USA), Professor K Bailey Freund (USA) and Professor Srinivas Sadda (USA).

In this episode, Carlos Pavesio (UK) and Sofia Androudi (Greece) share their experience and insights in the diagnosis and treatment of macular edema. Chaired by Bahram Bodaghi (France).

In this episode, we hear from Brent Dykes  about the importance of storytelling with data and how to implement it when communicating research. Brent is author of Effective Data Storytelling, founder of Analytics Hero and a regular contributor to Forbes.

In this episode, we explore the benefits of the Euretina Mentorship Programme. Guests are programme mentor and Euretina Board member, Dr Patricia Udaondo and Dara Conlon, Euretina Executive Vice President.

In January, The Lancet journal published studies showing that across 4 trials, faricimab improved and maintained vision in two leading causes of vision loss and reduced time between treatments. In this episode, we examine the results and implications of the research in an expert discussion chaired by Prof Anat Loewenstein (Tel Aviv Medical Centre) and Prof Reinier Schlingemann (Amsterdam University and Jules Gonin). They are joined by Ramin Tadayoni (Paris University), Professor Sandrine Zweifel (University Hospital Zurich) and Professor Usha Chakravarthy (Queen's University Belfast)

In this episode, Professors Heinrich Heimann (Liverpool University Hospital) and Jens Kiilgaard (Copenhagen University Hospital) chair a conversation about metastatic disease in uveal melanoma and a newly approved treatment, Tebentafusp. They’re joined by Dr Joseph Sacco (Liverpool University Hospital) and Dr Mette Bagger (Copenhagen University Hospital)

In this episode on inherited retinal diseases, we explore issues related to genetic testing: when it's needed, how access differs globally and when to refer patients to super specialist IRD centres. The discussion is chaired by Professor Bart LeRoy (Belgium) and Professor Isabelle Audo (Sorbonne France) with Dr Rola Ba-Abbad (Saudi Arabia) and Prof Graeme Black (UK).

In the first of our monthly Journal Clubs, Ferdinando Bottoni and Carsten Meyer present their publications on optic disc pit maculopathy and a retinal expansion technique for persistent macular holes respectively. A short synopisis of each paper is given below.

The papers were discussed with the authors by a panel chaired by David Steel, Grazia Pertile and Marta Figueroa.

Bottoni F, Cereda M, Secondi R, Bochicchio S, Staurenghi G. Vitrectomy for optic disc pit maculopathy: a long-term follow-up study. Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):675-682.

Synopsis: In a retrospective non-comparative study of patients with optic disc pit maculopathy treated with vitrectomy alone, complete resolution of fluid in and under the fovea was achieved in 8 of 10 eyes (80%) without additional treatment.  One additional patient experienced a retinal detachment requiring further surgery. In the successful cases macular detachment resolved in a mean of 14 months after surgery. Postoperative BCVA improved significantly from a mean of 0.63 logMAR compared to a preoperative mean of 0.27 logMAR.  Nine eyes (82%) had a postoperative BCVA of 0.5 or better.

The authors concluded that vitrectomy with induction of alone was a safe and successful therapeutic option for the treatment of optic disc pit maculopathy.

Vitrectomy for optic disc pit maculopathy: a long-term follow-up study - PubMed (nih.gov)

Meyer CH, Szurman P, Haritoglou C, Maier M, Wolf A, Lytvynchuk L, Priglinger S, Hillenkamp J, Wachtlin J, Becker M, Mennel S, Koss MJ. Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study. Graefes Arch Clin Exp Ophthalmol. 2020 Oct;258(10):2151-2161.

In a retrospective non-comparative study by 12 surgeons on 41 eyes with persistent macular holes, the authors reported on their initial surgical, anatomical and functional experience with a technique of retinal expansion by applying balanced saline solution underneath the edges of the holes to free up subretinal adhesions which they postulated had inhibited primary closure. The PMH were closed with this technique in 35 out of the 41 eyes (85%) at 6 weeks after surgery. The postoperative BCVA improved to 0.22 from 0.1 pre op. The application of SR-fluid was not associated with major intraoperative adverse effects. The authors concluded that the technique could achieve a fast and immediate anatomical closure in many cases without serious adverse events.

Application of subretinal fluid to close refractory full thickness macular holes: treatment strategies and primary outcome: APOSTEL study - PubMed (nih.gov)

In this first episode, Euretina’s new president Alistair Laidlaw discusses the future strategy and vision of the society with president-elect Ramin Tadayoni and General Secretary Professor Anat Loewenstein.